Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, ALS, and Huntington’s Disease, are on the rise worldwide. Yet, there are no effective therapies to cure, prevent, or treat most of these disorders.
To make progress, we launched the Neurodegeneration Challenge Network (NDCN) — bringing together experimental scientists from diverse research fields, along with computational biologists and physicians, to look at this problem across diseases.
Read how this effort is taking shape through the story of Rebecca and Elizabeth — a pair of NDCN researchers working together to treat and prevent rare neurodegenerative diseases that impact children.
Learn more about how the NDCN empowers scientists to pursue bold ideas in order to accelerate the science of neurodegeneration — and ultimately, the path to treatments.
News
Back to allRiddle of the sphinx
Probing the sphinx tile to explore geometry and chirality in life
How an urgent call from a family in Italy changed this scientist’s career
How virologist Ivan Marazzi was inspired to change the course of his career after a pivotal conversation with a concerned father seeking answers.
Dynamic duo: powerful new tools show cells in action
Ultrack and inTRACKtive, from scientists at CZ Biohub San Francisco, could shake up how biologists study development, cancer, the immune system, and more
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.
Cookies and JavaScript are required to access this form.